Average Co-Inventor Count = 8.11
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Schering Pharma Ag (8 from 192 patents)
2. Bayer Intellectual Property Gmbh (4 from 721 patents)
3. Bayer Pharma Aktiengesellschaft (3 from 378 patents)
4. Schering Aktiengesellschaft (1 from 1,384 patents)
15 patents:
1. 9604989 - Imidazopyridazines as Akt kinase inhibitors
2. 9340528 - Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
3. 9260435 - Substituted imidazopyrazines as Akt kinase inhibitors
4. 9206185 - Imidazopyridazines as Akt kinase inhibitors
5. 8975265 - Substituted imidazo[1,2-a]pyrimidines and —pyridines
6. 8957064 - Fused pyrimidines
7. 7906533 - Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
8. 7902229 - Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
9. 7846928 - Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
10. 7842809 - Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same
11. 7825114 - Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12. 7750000 - Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
13. 7572794 - Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
14. 7517894 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
15. 7202260 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones